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Abstract
Background
Mycetoma is a neglected, chronic, localized, progressively destructive, granulomatous in-
fection caused either by fungi (eumycetoma) or by aerobic actinomycetes (actinomyce-
toma). It is characterized by a triad of painless subcutaneous mass, multiple sinuses and
discharge containing grains. Mycetoma commonly affects young men aged between 20
and 40 years with low socioeconomic status, particularly farmers and herdsmen.
Methodology / Principal Findings
A 30 year-old male farmer from an ethnic minority in Phin District, Savannakhet Province,
Lao PDR (Laos) developed a painless swelling with multiple draining sinuses of his right
foot over a period of approximately 3 years. X-ray of the right foot showed osteolysis of tar-
sals and metatarsals. Aerobic culture of sinus discharge yielded large numbers of Staphylo-
coccus aureus and a slow growing Gram-positive rod. The organism was subsequently
identified as Nocardia aobensis by 16S ribosomal RNA gene sequencing. The patient re-
ceived antimicrobial treatment with amikacin and trimethoprim-sulfamethoxazole according
to consensus treatment guidelines. Although slight improvement was noted the patient left
the hospital after 14 days and did not take any more antibiotics. Over the following 22
weeks the swelling of his foot subsequently diminished together with healing of discharging
sinuses.
Conclusion
This is the first published case of Actinomycetoma caused by Nocardia aobensis and the
second case of Actinomycetoma from Laos. A treatment course of only 14 days with
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amikacin and trimethoprim-sulfamethoxazole was apparently sufficient to cure the infection,
although long-term treatment up to one year is currently recommended. Treatment trials or
prospective descriptions of outcome for actinomycetoma should investigate treatment effi-
cacy for the different members of Actinomycetales, particularly Nocardia spp., with short-
term and long-term treatment courses.
Author Summary
Mycetoma is a neglected tropical disease caused either by fungi or aerobic actinomycetes.
It predominantly affects poor people in remote communities, where access to health care
is very limited and people usually rely on traditional treatment. The incidence of myceto-
ma in the Lao PDR is not known, although the first case of mycetoma from the northern
part of the country was published only recently. The present case report is the second case
from the Lao PDR and the first published case of actinomycetoma caused by Nocardia
aobensis. Data from the literature and the present case suggest that far shorter courses of
antibiotics than those usually recommended might be sufficient to treat actinomycetoma
caused by Nocardia spp., although these observations need to be confirmed by further
studies. Shorter treatment courses would reduce drug side effects and the financial burden
on patients. The latter is particularly important for low-income countries like the Lao PDR
with very limited resources for health care.
Introduction
Mycetoma is a chronic, localized, progressively destructive, granulomatous infection caused ei-
ther by fungi (eumycetoma) or by aerobic actinomycetes (actinomycetoma). The disease was
added to the WHO list of neglected diseases and conditions in 2013 [1]. It is most likely ac-
quired by traumatic inoculation of the causative organism into the subcutaneous tissue, usually
of the foot although any part of the body can be affected. Mycetoma is characterized by a triad
of painless subcutaneous mass, multiple sinuses and discharge containing grains [2]. It com-
monly affects young adults, particularly males aged between 20 and 40 years. The male/female
ratio is approximately 3:1. People of low socioeconomic status and manual workers such as
farmers, labourers and herdsmen are most frequently affected [3,4]. Consensus treatment
guidelines for eumycetoma and actinomycetoma recommend long-term treatment over 6–12
months with antifungal or antibacterial drugs [5]. However no comparative clinical trials of
treatment of this condition have ever been undertaken. It is possible that the taxonomically di-
verse range of causative agents of eumycetoma and actinomycetoma may require more differ-
entiated therapeutic regimens. Here we report a case of actinomycetoma caused by Nocardia
aobensis, which was cured after short-term antibiotic treatment.
Materials and Methods
Ethics statement
Written informed consent was obtained from the patient for publication of this case report and
any accompanying images. The board of directors of Lao-Oxford-Mahosot Hospital Wellcome
Trust Research Unit, Bernhard Nocht Institute for Tropical Medicine and Savannakhet provin-
cial hospital approved this case report for publication.
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Medical history
A 30 year-old male farmer from an ethnic minority group in Phin District, Savannakhet Prov-
ince, Lao PDR, reported the development of a painless swelling of his right foot over approxi-
mately 3 years. He had no history of trauma or animal bites. Multiple draining sinuses
developed over time discharging serous fluid.
Clinical examination
The patient was afebrile with normal vital signs and physical examination was unremarkable
except for a massive tumour-like lesion of the right foot with multiple sinuses on the dorsal
and plantar surfaces (Fig 1A, 1B, and 1C).
Fig 1. Pictures A, B and C show the right foot before treatment, Pictures D, E and F show the foot 22
weeks after treatment.
doi:10.1371/journal.pntd.0003729.g001
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Laboratory results before treatment
WBC: 9500/μL, Hb: 5.5 mmol/L, HCT 31%, MCV: 58 fL, PLT: 568,000/μL Lymphocytes 22%,
Monocytes 14%, Granulocytes 64% Blood glucose: 4.2 mmol/l, creatinine: 53.1 μmol/l
Laboratory results 10 months after treatment
WBC: 7000/μL, Hb: 8.9 mmol/L, HCT 45%, MCV: 71 fL, PLT: 278,000/μL Lymphocytes 24%,
Monocytes 7%, Granulocytes 69% creatinine: 70.8 μmol/l
X-ray of the right foot before treatment
X-ray of the right foot before treatment showed osteolysis of tarsals and metatarsal, particularly
metatarsals II–V, the cuneiforms and cuboid and a pathologic fracture at the base of metatarsal
V. (Fig 2A).
X-ray of the right foot 10 months after treatment
X-ray of the right foot 10 months after treatment showed significant improvement at the meta-
tarsal shafts II–V with healing of the fracture at metatarsal V, but still osteolysis at metatarsal
bases II–V, the cuneiforms and cuboid. Joint lines between metatarsals and tarsals are not iden-
tifiable (Fig 2B).
Microbiological and molecular biological results
Aerobic culture of sinus discharge yielded large numbers of Staphylococcus aureus and a slow
growing Gram-positive rod, which was apparent after 5 days’ incubation (Fig 3B). Gram stain
preparation showed branching Gram-positive rods (Fig 3A). The organism was identified as
Fig 2. X-ray of right foot before (A) and 10months after treatment (B).
doi:10.1371/journal.pntd.0003729.g002
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Nocardia aobensis in two independent laboratories after amplification and sequencing of the
16S ribosomal RNA gene (839bp: coverage 839/839, identity 100%, e-value 0.00, Accession
Number KP250991; 670bp [hypervariable regions V3–V7]: coverage 670/670, identity 100%,
e-value 0.00, Accession Number KP404096) and blast analysis against the NCBI database [6].
Clinical diagnosis
Mycetoma
Microbiological diagnosis
Actinomycetoma caused by Nocardia aobensis
Treatment
The patient received amikacin (15mg/kg/day) intravenously combined with trimethoprim-
sulfamethoxazole (TMP-SMX) (7/35 mg/kg/day) per os for 14 days. Although slight improve-
ment was noted at that stage, with a decrease of discharge and closure of sinuses, the patient
left the hospital against medical advice for traditional treatment in his village and did not take
any more antibiotics (Fig 4). Over the following weeks the swelling of his foot subsequently di-
minished together with healing of discharging sinuses. This was confirmed when he was seen
22 and 43 weeks after antibiotic treatment at the health centre in his village and the provincial
hospital (Fig 1D, 1E, and 1F). He resumed physical work in the forest without limitation and
reported a significant overall improvement of his state of health. X-ray of his right foot showed
significant improvement at the metatarsal shafts, but still signs of osteolysis at the metatarsal
bases, the cuneiforms and cuboid. The initial anaemia and thrombocythaemia, most likely the
result of chronic infection, returned to normal 10 months after treatment.
Discussion
The incidence of mycetoma in Laos is not known. Only one case of actinomycetoma, caused by
Actinomadura madurae, from Xieng Khouang province in the northern part of the country has
been published [7].
The patient’s history and the clinical appearance of his foot were suggestive of mycetoma
and microbiological culture and molecular biological identification of Nocardia aobensis
Fig 3. (A) Gram stain preparation showing branching Gram-positive rods, (B) Chocolate agar showing
heavy growth of Staphylococcus aureuswith scattered colonies of Nocardia aobensis (5 days’
incubation).
doi:10.1371/journal.pntd.0003729.g003
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confirmed the diagnosis of actinomycetoma. Correct identification of the causative agent is
crucial in order to choose the appropriate treatment.
More than 30 species have so far been identified as aetiological agents of mycetoma world-
wide [8]. Actinomadura madurae, Actinomadura pelletieri, Nocardia brasiliensis, Nocardia
asteroides and Streptomyces somaliensis are most frequently responsible for causing actinomy-
cetoma [4]. The patient described is to our knowledge the first confirmed case of actinomyce-
toma caused by Nocardia aobensis and adds one more causative agent to the list. Nocardia
aobensis was first described in 2004 after having been isolated from sputum of Japanese pa-
tients [9]. Antimicrobial susceptibility testing has not been done for the isolate described here,
but most Nocardia spp. including Nocardia aobensis, are susceptible to amikacin and
TMP-SMX [10].
In 1987, Welsh et al. reported a study which included 15 patients treated for actinomyce-
toma, all but one of which were caused by Nocardia brasiliensis, with cycles of amikacin alone
(2 cases) and amikacin with TMP-SMX (13 cases). Treatment with amikacin 15mg/kg/day for
3 weeks together with TMP-SMX 7/35mg/kg/day for 5 weeks was defined as 1 cycle. The pa-
tients were all cured after 1–3 cycles, with 4 patients cured after 1 cycle, 8 patients cured after 2
cycles and 3 patients cured after 3 cycles [11,12]. In 1982 a young man with severe actinomyce-
toma and pulmonary involvement caused by Nocardia brasiliensis was successfully treated
with one cycle [13]. Based on their experience with 56 patients Welsh et al. recommend 1–4 cy-
cles with amikacin and TMP-SMX in severe cases of actinomycetoma that do not respond to
Fig 4. Right foot after 14 days of treatment with amikacin and trimethoprim-sulfamethoxazole. Sinuses
were closed and no more discharge observed.
doi:10.1371/journal.pntd.0003729.g004
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TMP-SMX alone, achieving a cure rate of approximately 90% [5]. The number of cycles is de-
pendent on the clinical and bacteriological response and varies from case to case. In our pa-
tient, a clinical improvement with closure of sinuses was noted after only two weeks of
amikacin and TMP-SMX (Fig 4). Swelling was still significant at that time and took 22 weeks
to resolve, which under normal circumstances might have misled the clinician in charge to con-
tinue the treatment for a longer period, although it appears that cure had already been achieved
after 2 weeks. Current practice may thus entail some “overkill”. However, although haemoglo-
bin and platelet count returned to normal values 43 weeks after treatment, radiological changes
of metatarsal and tarsal bones had not completely disappeared at that time and this requires
further follow up, because recurrence 2 years after remission has been previously reported [5].
Clinical trials or prospective descriptions with short-term and long-term antimicrobial
treatment courses and longer periods of follow up are needed to inform optimal antibiotics and
particularly treatment duration. Actinomycetoma affects mostly poor villagers in remote com-
munities and shorter treatment courses would significantly reduce the financial burden and
side effects of amikacin and TMP-SMX.
Conclusion
To our knowledge this is the first published patient with actinomycetoma caused by Nocardia
aobensis and the second case of actinomycetoma from Laos. A treatment course of only 14
days with amikacin and TMP-SMX appears to have been sufficient to cure the infection as de-
fined by 43 weeks follow up. Trials or prospective descriptions of efficacy of different antimi-
crobial therapy with short-term and long-term treatment courses for actinomycetoma should
investigate treatment outcome separately for different members of Actinomycetales, particular-
ly Nocardia spp.
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